Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Paula Oliveira Gomes has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of Osteoblast‐Extracellular Matrix‐Functionalized Nanostructured Titanium Surface on Osteoblastic Cell Behavior

    by Georgia Kors Quiles, Paola Gomes Souza, Maria Paula Oliveira Gomes, Rayana Longo Bighetti‐Trevisan, Leticia Faustino Adolpho, Helena Bacha Lopes, Adalberto Luiz Rosa, Marcio Mateus Beloti

    Nanostructured titanium (Ti) facilitates osteoblast differentiation by modulating various signaling pathways and may enhance osseointegration, potentially through its influence on the formation and remodeling of the extracellular matrix (ECM). This study aimed to investigate the impact of osteoblast‐ECM‐functionalized nanostructured Ti surface on osteoblastic cell behavior. Initially, it was demonstrated that nanotopography upregulated the expression of genes associated with ECM formation and remodeling in MC3T3‐E1 osteoblastic cells compared to a polished Ti surface. Then, MC3T3‐E1 cells were cultured on nanotopography, and the cultures were decellularized to generate ECM‐functionalized nanostructured Ti surface. Successful decellularization was verified by 4′,6‐diamidino‐2‐phenylindole staining for DNA, DNA quantification, fibronectin immunodetection and scanning electron microscopy. To investigate the effect of ECM functionalization on osteoblasts, calvaria‐derived osteoblasts were cultured on both non‐functionalized and osteoblast‐ECM‐functionalized nanostructured Ti surfaces. ECM functionalization did not affect cell morphology but reduced proliferation and the gene expression of osteoblastic markers while increasing alkaline phosphatase activity and ECM mineralization. Additionally, RAW 264.7 osteoclastic cells cultured on ECM‐functionalized surface exhibited higher tartrate‐resistant acid phosphatase activity. Functionalization of nanostructured Ti surfaces created a favorable microenvironment for bone cell activity and bone remodeling, contributing to the development of smart osseointegrated Ti implants.

  • Open Access

    Agrin Ablation in Osteoblasts Compromises Long Bone Structure and Osteoblastic Differentiation of Mesenchymal Stem Cells

    by Gabriela Camarneiro Siqueira, Maria Paula Oliveira Gomes, Letícia Faustino Adolpho, Aline Ying Ying Wang, Fabiola Singaretti Olveira, Adriana Luisa Gonçalves Almeida, Roger Rodrigo Fernandes, Ana Paula Macedo, Ana Paula Ramos, Adalberto Luiz Rosa, et al.

    Agrin is an important factor in maintaining skeletal architecture. However, the role of osteoblast‐expressed agrin in bone tissue remains unexplored. Thus, we hypothesized that agrin‐deficient osteoblasts negatively affect bone tissue homeostasis by disrupting osteoblastic differentiation of mesenchymal stem cells (MSCs). To investigate this hypothesis, mice with deletion of agrin in Runx2‐expressing osteoblasts were generated using Runx2‐Cre mice. Microtomographic analyses revealed that agrin ablation in osteoblasts resulted in deleterious effects on the cortical bone of the femurs, leading to a tendency towards reduced bone stiffness, as indicated by the three‐point bending test. This negative impact of agrin‐deficient osteoblasts on bone tissue may be partially attributed to the reduced osteoblastic differentiation of MSCs derived from these mice, as evidenced by lower expression of osteoblastic marker genes and alkaline phosphatase activity. This disruption in osteoblastic differentiation is directly linked to agrin‐deficient osteoblasts, as demonstrated by diminished gene expression of agrin and its receptors in MSCs collected from these animals. Our findings highlight the role of osteoblast‐secreted agrin in maintaining long bone structure, mainly by promoting MSC differentiation into osteoblasts. The findings indicate that agrin could be an effective therapeutic target for treating bone loss‐related conditions, such as osteoporosis and aging.

  • Sfrp4 Is Required for Proper Dental Formation and Stem Cell Regulation

    by G. Sarra, S. Parsaei, M.P. Gomes, Y.-C. Lin, A.C. Pedroni, D. Raval, D. Hu, S. Berry, R. Baron, F.B. Bidlack, et al.

    Our studies have established that loss-of-function mutations in the Wnt signaling antagonist SFRP4 (Secreted Frizzled Related Protein 4) cause Pyle disease, a rare skeletal disease characterized by limb deformity. Pyle disease can also present with a number of dental conditions, including tooth decay and taurodontism. Aside from the sparse clinical descriptions of the tooth anomalies seen in Pyle disease, the role of Sfrp4 in teeth has not been investigated. Here we show that in adult mouse incisors, Sfrp4 is expressed in the mesenchymal and epithelial compartments and their derivatives as well in the developing apex of the molar roots, pulp, odontoblasts, and periodontal ligament. We report that Sfrp4 deletion in mice leads to markedly shorter incisors, with reduced dentin mineral apposition and enamel volume. In addition, we find that Sfrp4 deletion leads to a reduction in the root length and bifurcation height of the developing molars, both features of taurodontism. Rodent incisors grow continuously during the animal’s lifetime, thanks to the maintenance and interactions of epithelial (EpSCs) and mesenchymal stem cells (MSCs) at their apex. As such, the mouse incisor is a powerful tool for studying adult stem cells, their interactions, and their regulation. Using this model, we found that Sfrp4 deletion leads to a significant decrease in Gli1 + MSCs and in Ki67 levels in mesenchymal transient amplifying cells and preameloblasts. Sfrp4 -null incisors have reduced type I collagen levels and altered amelogenin and Mmp20 secretion accompanied by changes in the enamel maturation stages. When incisor growth is accelerated by preventing occlusion through tooth clipping, Sfrp4 -null incisors grow significantly slower than wt incisors do. Our study suggests a key role for Sfrp4 in the fast-growing teeth (incisors) and developing molars, where there is a need to balance the maintenance and differentiation of the stem cell niche.


  • Diabetes Mellitus Impairs the Bone Regeneration Capacity of Mesenchymal Stromal Cell-Based Therapy

    by Alann Thaffarell Portilho Souza, Gileade Pereira Freitas, Helena Bacha Lopes, Denise Weffort, Leticia Faustino Adolpho, Maria Paula Oliveira Gomes, Fabiola Singaretti Oliveira, Adriana Luisa Gonçalves Almeida, Marcio Mateus Beloti, Adalberto Luiz Rosa


  • Open Access

    Diabetes mellitus impairs the bone regeneration capacity of mesenchymal stem cell-based therapy

    by Alann Thaffarell Portilho Souza, Gileade Pereira Freitas, Helena Bacha Lopes, Denise Weffort, Leticia Faustino Adolpho, Maria Paula Oliveira Gomes, Fabiola Singaretti Oliveira, Adriana Luisa Gonçalves Almeida, Marcio Mateus Beloti, Adalberto Luiz Rosa

    BACKGROUND Diabetes mellitus (DM) negatively impacts bone tissue, leading to bone loss and increased fracture risk with many in need of additional treatments, and therapy based on mesenchymal stem cells (MSCs) represents a promising treatment for bone defects in patients with diabetes. The present investigation explored the interactions between MSCs from normoglycemic (NG-MSCs) and diabetic (DM-MSCs) donors on osteoblast differentiation and the effects of NG-MSCs on bone regeneration in defects created in diabetic rats. METHODS After DM induction with streptozotocin, we evaluated the morphometric parameters of femurs and MSC osteoblast differentiation, as well as the effects of the interactions between NG-MSCs and DM-MSCs on osteoblast differentiation. The efficacy of cell therapy was measured by evaluating bone regeneration in the calvarial defects of diabetic rats treated with local injection of either NG-MSCs or vehicle. RESULTS DM induced bone loss and impaired osteoblast differentiation of MSCs, which was partially restored by NG-MSCs, and the bone formation observed in defects treated with either NG-MSCs or vehicle was similar. CONCLUSION These findings indicate that the beneficial effect of NG-MSCs on DM-MSCs did not translate to enhanced bone repair, mostly due to the hostile environment created by hyperglycemia, which compromises the capacity of MSCs to induce bone formation.

  • Open Access

    Jaboticaba Peel Extract Attenuates Ovariectomy-Induced Bone Loss by Preserving Osteoblast Activity

    by Letícia Faustino Adolpho, Maria Paula Oliveira Gomes, Gileade Pereira Freitas, Rayana Longo Bighetti-Trevisan, Jaqueline Isadora Reis Ramos, Gabriela Hernandes Campeoti, Guilherme Crepi Zatta, Adriana Luisa Gonçalves Almeida, Adriana Gadioli Tarone, Mario Roberto Marostica-Junior, et al.

    Therapies to prevent osteoporosis are relevant since it is one of the most common non-communicable human diseases in the world and the most prevalent bone disorder in adults. Since jaboticaba peel extract (JPE) added to the culture medium enhanced the osteogenic potential of mesenchymal stem cells (MSCs) derived from osteoporotic rats, we hypothesized that JPE prevents the development of ovariectomy-induced osteoporosis. Ovariectomized rats were treated with either JPE (30 mg/kg of body weight) or its vehicle for 90 days, starting 7 days after the ovariectomy. Then, the femurs were subjected to microcomputed tomography and histological analyses, and the osteoblast and adipocyte differentiation of MSCs was evaluated. JPE attenuated ovariectomy-induced bone loss, as evidenced by higher bone volume/total volume and trabecular number, along with lower trabecular separation and bone marrow adiposity. These protective effects of JPE on bone tissue are due to its ability to prevent the imbalance between osteoblast and adipocyte differentiation of MSCs, since, compared with MSCs derived from ovariectomized rats treated with vehicle, MSCs treated with JPE exhibited higher gene and protein expression of osteogenic markers and extracellular matrix mineralization, as well as lower gene expression of adipogenic markers. These data highlight the potential therapeutic use of JPE to prevent osteoporosis.


  • Efficacy of mesenchymal stem cell‐based therapy on the bone repair of hypertensive rats

    by Alann Thaffarell Portilho Souza, Gileade Pereira Freitas, Helena Bacha Lopes, Denise Weffort, Leticia Faustino Adolpho, Maria Paula Oliveira Gomes, Fabiola Singaretti Oliveira, Adriana Luisa Gonçalves Almeida, Marcio Mateus Beloti, Adalberto Luiz Rosa

    Objective: Hypertension disrupts the bone integrity and its repair ability. This study explores the efficiency of a therapy based on the application of mesenchymal stem cells (MSCs) to repair bone defects of spontaneously hypertensive rats (SHR).Methods: First, we evaluated SHR in terms of bone morphometry and differentiation of MSCs into osteoblasts. Then, the effects of the interactions between MSCs from normotensive rats (NTR‐MSCs) cocultured with SHR (SHR‐MSCs) on the osteoblast differentiation of both cell populations were evaluated. Also, bone formation into calvarial defects of SHR treated with NTR‐MSCs was analyzed.Results: Hypertension induced bone loss evidenced by reduced bone morphometric parameters of femurs of SHR compared with NTR as well as decreased osteoblast differentiation of SHR‐MSCs compared with NTR‐MSCs. NTR‐MSCs partially restored the capacity of SHR‐MSCs to differentiate into osteoblasts, while SHR‐MSCs exhibited a slight negative effect on NTR‐MSCs. An enhanced bone repair was observed in defects treated with NTR‐MSCs compared with control, stressing this cell therapy efficacy even in bones damaged by hypertension.Conclusion: The use of MSCs derived from a heathy environment can be in the near future a smart approach to treat bone loss in the context of regenerative dentistry for oral rehabilitation of hypertensive patients.


  • Mesenchymal stem cell-based therapy for osteoporotic bones: Effects of the interaction between cells from healthy and osteoporotic rats on osteoblast differentiation and bone repair

    by Alann Thaffarell Portilho Souza, Gileade Pereira Freitas, Helena Bacha Lopes, Denise Weffort, Leticia Faustino Adolpho, Maria Paula Oliveira Gomes, Fabiola Singaretti Oliveira, Adriana Luisa Gonçalves Almeida, Marcio Mateus Beloti, Adalberto Luiz Rosa


  • Open Access

    Mesenchymal Stem Cells Combined with a P(VDF-TrFE)/BaTiO3 Scaffold and Photobiomodulation Therapy Enhance Bone Repair in Rat Calvarial Defects

    by Leticia Faustino Adolpho, Larissa Mayra Silva Ribeiro, Gileade Pereira Freitas, Helena Bacha Lopes, Maria Paula Oliveira Gomes, Emanuela Prado Ferraz, Rossano Gimenes, Marcio Mateus Beloti, Adalberto Luiz Rosa

    Background: Tissue engineering and cell therapy have been the focus of investigations on how to treat challenging bone defects. This study aimed to produce and characterize a P(VDF-TrFE)/BaTiO3 scaffold and evaluate the effect of mesenchymal stem cells (MSCs) combined with this scaffold and photobiomodulation (PBM) on bone repair. Methods and results: P(VDF-TrFE)/BaTiO3 was synthesized using an electrospinning technique and presented physical and chemical properties suitable for bone tissue engineering. This scaffold was implanted in rat calvarial defects (unilateral, 5 mm in diameter) and, 2 weeks post-implantation, MSCs were locally injected into these defects (n = 12/group). Photobiomodulation was then applied immediately, and again 48 and 96 h post-injection. The μCT and histological analyses showed an increment in bone formation, which exhibited a positive correlation with the treatments combined with the scaffold, with MSCs and PBM inducing more bone repair, followed by the scaffold combined with PBM, the scaffold combined with MSCs, and finally the scaffold alone (ANOVA, p ≤ 0.05). Conclusions: The P(VDF-TrFE)/BaTiO3 scaffold acted synergistically with MSCs and PBM to induce bone repair in rat calvarial defects. These findings emphasize the need to combine a range of techniques to regenerate large bone defects and provide avenues for further investigations on innovative tissue engineering approaches.


  • Open Access

    Effects of rmBMP-7 on Osteoblastic Cells Grown on a Nanostructured Titanium Surface

    by Leonardo Raphael Zuardi, Fabíola Singaretti de Oliveira, Roger Rodrigo Fernandes, Maria Paula Oliveira Gomes, Silvia Spriano, Antonio Nanci, Paulo Tambasco de Oliveira

    This study evaluates the effects of the availability of exogenous BMP-7 on osteoblastic cells’ differentiation on a nanotextured Ti surface obtained by chemical etching (Nano-Ti). The MC3T3-E1 and UMR-106 osteoblastic cell lines were cultured for 5 and 7 days, respectively, on a Nano-Ti surface and on a control surface (Control-Ti) in an osteogenic medium supplemented with either 40 or 200 ng/mL recombinant mouse (rm) BMP-7. The results showed that MC3T3-E1 cells exhibited distinct responsiveness when exposed to each of the two rmBMP-7 concentrations, irrespective of the surface. Even with 40 ng/mL rmBMP-7, important osteogenic effects were noticed for Control-Ti in terms of cell proliferation potential; Runx2, Osx, Alp, Bsp, Opn, and Smad1 mRNA expression; and in situ ALP activity. For Nano-Ti, the effects were limited to higher Alp, Bsp, and Opn mRNA expression and in situ ALP activity. On both surfaces, the osteogenic potential of UMR-106 cultures remained unaltered with 40 ng/mL rmBMP-7, but it was significantly reduced when the cultures were exposed to the 200 ng/mL concentration. The availability of rmBMP-7 to pre-osteoblastic cells at the concentrations used alters the expression profile of osteoblast markers, indicative of the acquisition of a more advanced stage of osteoblastic differentiation. This occurs less pronouncedly on the nanotextured Ti and without reflecting in higher mineralized matrix production by differentiated osteoblasts on both surfaces.